Fundz

Akari Therapeutics Plc Appoints Abizer Gaslightwala as President and CEO

PUBLIC · AKTXMar 20, 2025

Position

Chief Executive Officer

Company

Akari Therapeutics

Abizer Gaslightwala
abizer.gaslightwala@akaritx.com
TampaBiotechnologyresearch

Description

Akari Therapeutics Plc announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer (CEO), effective April 21, 2025. He brings 25 years of experience in the biotechnology and pharmaceutical industry, having most recently served as the Senior Vice President and Franchise Head for US Oncology at Jazz Pharmaceuticals.

Quick answer

Akari Therapeutics Plc Appoints Abizer Gaslightwala as President and CEO (March 20, 2025). Akari Therapeutics is based in Tampa, Florida, United States.

Who is the new Chief Executive Officer at Akari Therapeutics?
Akari Therapeutics named Abizer Gaslightwala Chief Executive Officer, announced March 20, 2025.
What did Akari Therapeutics announce on March 20, 2025?
Akari Therapeutics Plc announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer (CEO), effective April 21, 2025. He brings 25 years of experience in the biotechnology and pharmaceutical industry, having most recently served as the Senior Vice President and Franchise Head for US Oncology at Jazz Pharmaceuticals.
What does Akari Therapeutics do?
Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells.
Where is Akari Therapeutics based?
Akari Therapeutics is based in Tampa, Florida, United States.
Which similar companies made leadership changes around the same time?
Cantargia AB (April 1, 2025), Algorae Pharmaceuticals (April 3, 2025), Wugen (February 26, 2025) and Climb Bio, Inc. (February 25, 2025) also announced leadership changes within 45 days of Akari Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in research and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Akari Therapeutics, and when

A new leader at Akari Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Akari Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akari Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Akari Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akari Therapeutics

Location

401 EAST JACKSON STREET

Tampa, Florida, United States

About

Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells. Unlike traditional ADC payloads, PH1 induces cancer cell death while activating immune responses, showing robust and durable activity in preclinical models.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akari Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mark
Likely contact at this company
••••••••@••••••••

See Mark's verified email →

Claire
Senior decision-maker at this company
••••••••@••••••••

See Claire's verified email →

John
Senior decision-maker at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Akari Therapeutics's next move

Learn about Strategic plan

Akari Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.